CIK 0001984086
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Septerna, Inc.
Sign in to watch- Ticker
- SEPN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843891440
- Phone
- +1 650-338-3533
- Business address
- 250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,017,100
- in 4 filings, $5.0M under 10b5-1 plans
Net −$5,017,100. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-15 | Bhatt Elizabeth President and COO | Exercise or conversion 10b5-1 | +4,000 | $6.81 | $27K | 178,209 |
| 2026-10-15 | Bhatt Elizabeth President and COO | Sale 10b5-1 | −1,094 | $36.87 | $40K | 177,115 |
| 2026-10-15 | Bhatt Elizabeth President and COO | Sale 10b5-1 | −2,906 | $37.61 | $109K | 174,209 |
| 2026-10-15 | Bhatt Elizabeth President and COO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −4,000 | 58,230 | ||
| 2026-08-11 | Bhatt Elizabeth President and COO | Exercise or conversion 10b5-1 | +18,681 | $6.81 | $127K | 192,890 |
| 2026-08-11 | Bhatt Elizabeth President and COO | Exercise or conversion 10b5-1 | +6,319 | $2.76 | $17K | 199,209 |
| 2026-08-11 | Bhatt Elizabeth President and COO | Sale 10b5-1 | −25,000 | $44.00 | $1.1M | 174,209 |
| 2026-08-11 | Bhatt Elizabeth President and COO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −18,681 | 62,230 | ||
| 2026-08-11 | Bhatt Elizabeth President and COO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −6,319 | 82,332 | ||
| 2026-07-15 | Bhatt Elizabeth President and COO | Exercise or conversion 10b5-1 | +4,000 | $6.81 | $27K | 178,209 |
| 2026-07-15 | Bhatt Elizabeth President and COO | Sale 10b5-1 | −4,000 | $33.99 | $136K | 174,209 |
| 2026-07-15 | Bhatt Elizabeth President and COO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −4,000 | 80,911 | ||
| 2026-04-15 | Bhatt Elizabeth President and COO | Exercise or conversion 10b5-1 | +4,000 | $6.81 | $27K | 178,209 |
| 2026-04-15 | Bhatt Elizabeth President and COO | Sale 10b5-1 | −2,573 | $23.76 | $61K | 175,636 |
| 2026-04-15 | Bhatt Elizabeth President and COO | Sale 10b5-1 | −1,101 | $25.24 | $28K | 174,535 |
| 2026-04-15 | Bhatt Elizabeth President and COO | Sale 10b5-1 | −326 | $25.86 | $8K | 174,209 |
| 2026-04-15 | Bhatt Elizabeth President and COO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −4,000 | 84,911 | ||
| 2026-02-18 | Bhatt Elizabeth President and COO | Exercise or conversion 10b5-1 | +4,000 | $6.81 | $27K | 178,209 |
| 2026-02-18 | Bhatt Elizabeth President and COO | Sale 10b5-1 | −2,200 | $28.46 | $63K | 176,009 |
| 2026-02-18 | Bhatt Elizabeth President and COO | Sale 10b5-1 | −1,800 | $29.58 | $53K | 174,209 |
Page 1 of 2 · 23 trades